Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  isotretinoin
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Chemotherapy and Radiation Therapy in Treating Young Patients with Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 3 to 21
Trial IDs: ACNS0332, NCI-2009-00336, CDR0000511991, COG-ACNS0332, NCT00392327
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients with Non-high Risk Neuroblastoma
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 17 months and under
Trial IDs: ANBL1232, NCI-2014-00677, NCT02176967
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients with Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Not yet active
Phase: Phase III
Type: Treatment
Age: 365 days to 30 years
Trial IDs: ANBL1531, NCI-2016-01734, NCT03126916
Humanized Monoclonal Antibody 3F8, Sargramostim, and Isotretinoin in Treating Patients with High-Risk Neuroblastoma in First Remission
Status: Active
Phase: Phase II
Type: Treatment
Age: Any age
Trial IDs: 16-1643, NCI-2017-00121, NCT03033303
Lenalidomide and Dinutuximab with or without Isotretinoin in Treating Younger Patients with Refractory or Recurrent Neuroblastoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and under
Trial IDs: NANT N2011-04, NCI-2012-02011, CDR0000741991, N2011-04, NANT 11-04, NCT01711554
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients with High-Risk Neuroblastoma
Status: Active
Phase: No phase specified
Type: Treatment
Age: Not specified
Trial IDs: 13-260, NCI-2014-00815, NCT02100930
Start Over